CAS 1698024-73-5

Fórmula: C21H17ClF2N4O2

InChI: InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25-11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2

Chave InChI: ZRPZPNYZFSJUPA-UHFFFAOYSA-N

SMILES: C=CC(=O)N1CCN(CC1)C2=NC=NC3=C(C(=C(C=C32)Cl)C4=C(C=CC=C4F)O)F

ARS-1323

CAS: 1698024-73-5

ARS-1323

Fórmula: C₂₁H₁₇ClF₂N₄O₂

Pureza: ≥98%

Peso molecular: 430.84

Ref: 54-BUP07005

ARS-1323

CAS: 1698024-73-5

Fórmula: C₂₁H₁₇ClF₂N₄O₂

Peso molecular: 430.8351

Ref: IN-DA01EOLG

ARS-1620

CAS: 1698024-73-5

ARS-1620 is a small-molecule inhibitor, which is derived from advanced medicinal chemistry efforts focused on targeting specific oncogenic mutations. This compound is synthesized with the precise intent to address challenges posed by mutant KRAS G12C, a particularly intractable target given its prevalence in various cancers such as lung and colorectal cancers.

Fórmula: C₂₁H₁₇ClF₂N₄O₂

Pureza: Min. 95%

Peso molecular: 430.84 g/mol

Ref: 3D-YSC02473

ARS-1323

CAS: 1698024-73-5

ARS-1323 is the racemate of ARS-1620 and a mutant K-ras G12C inhibitor.

Fórmula: C₂₁H₁₇ClF₂N₄O₂

Pureza: 99.53%

Cor e Forma: Solid

Peso molecular: 430.84

Ref: TM-T10375